UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk?

Pharmacotherapy, 2016-06, Vol.36 (6), p.679-693

2016

Volltextzugriff (PDF)

Approach to the Treatment of Patients with Serious Multidrug‐Resistant Pseudomonas aeruginosa Infections

Pharmacotherapy, 2020-09, Vol.40 (9), p.952-969

2020

Volltextzugriff (PDF)

A Case Series of Rifabutin Use in Staphylococcal Prosthetic Infections

Microbiology spectrum, 2022-06, Vol.10 (3), p.e0038422

2022

Volltextzugriff (PDF)

Use of Oral Tetracyclines in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia: A Literature Review on the Often-Overlooked Antibiotic Class

Antibiotics (Basel), 2020-12, Vol.9 (12), p.905

2020

Volltextzugriff (PDF)

Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline

Pharmacotherapy, 2021-11, Vol.41 (11), p.915-931

2021

Volltextzugriff (PDF)

Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19

Journal of the American Society of Nephrology, 2020-07, Vol.31 (7), p.1384-1386

2020

Volltextzugriff (PDF)

Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need

Infectious diseases and therapy, 2016-09, Vol.5 (3), p.299-312

2016

Volltextzugriff (PDF)

Fluoroquinolone and Third-Generation-Cephalosporin Resistance among Hospitalized Patients with Urinary Tract Infections Due to Escherichia coli: Do Rates Vary by Hospital Characteristics and Geographic Region?

Antimicrobial agents and chemotherapy, 2016-05, Vol.60 (5), p.3170-3173

2016

Volltextzugriff (PDF)

Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study

BMC infectious diseases, 2017-08, Vol.17 (1), p.534-534, Article 534

2017

Volltextzugriff (PDF)

Gut microbiome health and dysbiosis: A clinical primer

Pharmacotherapy, 2022-11, Vol.42 (11), p.849-857

2022

Volltextzugriff (PDF)

Remdesivir use and outcomes during the FDA COVID-19 emergency use authorization period

Therapeutic advances in infectious disease, 2021, Vol.8, p.204993612110466

2021

Volltextzugriff (PDF)

Suboptimal Clinical Response Rates with Newer Antibiotics Among Patients with Moderate Renal Impairment: Review of the Literature and Potential Pharmacokinetic and Pharmacodynamic Considerations for Observed Findings

Pharmacotherapy, 2018-12, Vol.38 (12), p.1205-1215

2018

Volltextzugriff (PDF)

Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins

Journal of antimicrobial chemotherapy, 2018-10, Vol.73 (10), p.2643-2651

2018

Volltextzugriff (PDF)

Fecal Microbiota, Live-jslm for the Prevention of Recurrent Clostridioides difficile Infection: Subgroup Analysis of PUNCH CD2 and PUNCH CD3

Journal of clinical gastroenterology, 2024-09, Vol.58 (8), p.818-824

2024

Volltextzugriff (PDF)

Fidaxomicin-Associated Hypersensitivity Reactions: Report of a Morbilliform Drug Eruption

Journal of pharmacy practice, 2023-08, Vol.36 (4), p.993-997

2023

Volltextzugriff (PDF)

Characterization of the haematological profile of 21 days of tedizolid in healthy subjects

Journal of antimicrobial chemotherapy, 2016-09, Vol.71 (9), p.2553-2558

2016

Volltextzugriff (PDF)

Colistin Nephrotoxicity: Meta-Analysis of Randomized Controlled Trials

Open forum infectious diseases, 2021-02, Vol.8 (2), p.ofab026

2021

Volltextzugriff (PDF)

Effect of oral vancomycin dose on outcomes in patients with Clostridioides difficile infection

International journal of antimicrobial agents, 2021-04, Vol.57 (4), p.106311-106311, Article 106311

2021

Volltextzugriff (PDF)

Effect of prior receipt of antibiotics on the pathogen distribution and antibiotic resistance profile of key Gram-negative pathogens among patients with hospital-onset urinary tract infections

BMC infectious diseases, 2017-02, Vol.17 (1), p.176-176, Article 176

2017

Volltextzugriff (PDF)

Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), Among Patients Exposed to Non– Clostridioides difficile Infection Antibiotics: Post Hoc Subgroup Analysis of a Phase 2 Open-Label Study

Open forum infectious diseases, 2024-07, Vol.11 (7), p.ofae341

2024

Volltextzugriff (PDF)

Therapeutic drug monitoring of flucytosine in a cardiac transplant patient receiving continuous veno‐venous hemofiltration and intermittent hemodialysis: A case report

Transplant infectious disease, 2021-08, Vol.23 (4), p.e13575-n/a

2021

Volltextzugriff (PDF)

793. Rifabutin Use in Staphylococcal Prosthetic Material Infections: A Case Series

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S492-S493

2021

Volltextzugriff (PDF)

61. Evaluation of the Impact of a Micafungin Time-Out Protocol for Hospitalized Patients

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S51-S51

2020

Volltextzugriff (PDF)

1482. Local validation of the drug resistance in pneumonia clinical prediction score at a large academic medical center and a community hospital

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S742-S743

2020

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(28)
Buchkapitel
(1)

Sprache

Englisch
(29)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(20)
Infectious Diseases
(13)
Humans
(11)
Pharmacology & Pharmacy
(10)
Patients
(9)
Microbiology
(8)
Antibiotics
(7)
Risk Factors
(6)
Pharmacokinetics
(5)
Female
(4)
Male
(4)
Pharmacodynamics
(4)
Retrospective Studies
(4)
Adult
(3)
Anti-Bacterial Agents - Administration & Dosage
(3)
Anti-Bacterial Agents - Adverse Effects
(3)
Anti-Bacterial Agents - Pharmacokinetics
(3)
Clinical Trials
(3)
Covid-19
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk?

Approach to the Treatment of Patients with Serious Multidrug‐Resistant Pseudomonas aeruginosa Infections

A Case Series of Rifabutin Use in Staphylococcal Prosthetic Infections

Use of Oral Tetracyclines in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia: A Literature Review on the Often-Overlooked Antibiotic Class

Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline

Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19

Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need

Fluoroquinolone and Third-Generation-Cephalosporin Resistance among Hospitalized Patients with Urinary Tract Infections Due to Escherichia coli: Do Rates Vary by Hospital Characteristics and Geographic Region?

Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study

Gut microbiome health and dysbiosis: A clinical primer

Remdesivir use and outcomes during the FDA COVID-19 emergency use authorization period

Suboptimal Clinical Response Rates with Newer Antibiotics Among Patients with Moderate Renal Impairment: Review of the Literature and Potential Pharmacokinetic and Pharmacodynamic Considerations for Observed Findings

Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins

Fecal Microbiota, Live-jslm for the Prevention of Recurrent Clostridioides difficile Infection: Subgroup Analysis of PUNCH CD2 and PUNCH CD3

Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study

Fidaxomicin-Associated Hypersensitivity Reactions: Report of a Morbilliform Drug Eruption

Characterization of the haematological profile of 21 days of tedizolid in healthy subjects

Colistin Nephrotoxicity: Meta-Analysis of Randomized Controlled Trials

Effect of oral vancomycin dose on outcomes in patients with Clostridioides difficile infection

Effect of prior receipt of antibiotics on the pathogen distribution and antibiotic resistance profile of key Gram-negative pathogens among patients with hospital-onset urinary tract infections

Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), Among Patients Exposed to Non– Clostridioides difficile Infection Antibiotics: Post Hoc Subgroup Analysis of a Phase 2 Open-Label Study

Therapeutic drug monitoring of flucytosine in a cardiac transplant patient receiving continuous veno‐venous hemofiltration and intermittent hemodialysis: A case report

793. Rifabutin Use in Staphylococcal Prosthetic Material Infections: A Case Series

61. Evaluation of the Impact of a Micafungin Time-Out Protocol for Hospitalized Patients

1482. Local validation of the drug resistance in pneumonia clinical prediction score at a large academic medical center and a community hospital

Suchergebnisse filtern